260 related articles for article (PubMed ID: 11175744)
41. Xaf1 can cooperate with TNFalpha in the induction of apoptosis, independently of interaction with XIAP.
Xia Y; Novak R; Lewis J; Duckett CS; Phillips AC
Mol Cell Biochem; 2006 Jun; 286(1-2):67-76. PubMed ID: 16432762
[TBL] [Abstract][Full Text] [Related]
42. Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor.
Fang X; Liu Z; Fan Y; Zheng C; Nilson S; Egevad L; Ekman P; Xu D
Int J Cancer; 2006 May; 118(10):2485-9. PubMed ID: 16353137
[TBL] [Abstract][Full Text] [Related]
43. XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.
Zou B; Chim CS; Pang R; Zeng H; Dai Y; Zhang R; Lam CS; Tan VP; Hung IF; Lan HY; Wong BC
Mol Carcinog; 2012 May; 51(5):422-32. PubMed ID: 21678496
[TBL] [Abstract][Full Text] [Related]
44. The role of XAF1 in cancer.
Plenchette S; Cheung HH; Fong WG; LaCasse EC; Korneluk RG
Curr Opin Investig Drugs; 2007 Jun; 8(6):469-76. PubMed ID: 17621877
[TBL] [Abstract][Full Text] [Related]
45. XAF1 expression is significantly reduced in human melanoma.
Ng KC; Campos EI; Martinka M; Li G
J Invest Dermatol; 2004 Dec; 123(6):1127-34. PubMed ID: 15610524
[TBL] [Abstract][Full Text] [Related]
46. XIAP: apoptotic brake and promising therapeutic target.
Holcik M; Gibson H; Korneluk RG
Apoptosis; 2001 Aug; 6(4):253-61. PubMed ID: 11445667
[TBL] [Abstract][Full Text] [Related]
47. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions.
Shin CH; Lee MG; Han J; Jeong SI; Ryu BK; Chi SG
Proc Natl Acad Sci U S A; 2017 May; 114(22):5683-5688. PubMed ID: 28507149
[TBL] [Abstract][Full Text] [Related]
48. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro.
Bilim V; Kasahara T; Hara N; Takahashi K; Tomita Y
Int J Cancer; 2003 Jan; 103(1):29-37. PubMed ID: 12455050
[TBL] [Abstract][Full Text] [Related]
49. Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell cultures.
Sauerwald TM; Figueroa B; Hardwick JM; Oyler GA; Betenbaugh MJ
Biotechnol Bioeng; 2006 Jun; 94(2):362-72. PubMed ID: 16598795
[TBL] [Abstract][Full Text] [Related]
50. Inhibiting apoptosis in mammalian cell culture using the caspase inhibitor XIAP and deletion mutants.
Sauerwald TM; Betenbaugh MJ; Oyler GA
Biotechnol Bioeng; 2002 Mar; 77(6):704-16. PubMed ID: 11807766
[TBL] [Abstract][Full Text] [Related]
51. XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway.
Straszewski-Chavez SL; Visintin IP; Karassina N; Los G; Liston P; Halaban R; Fadiel A; Mor G
J Biol Chem; 2007 Apr; 282(17):13059-72. PubMed ID: 17329253
[TBL] [Abstract][Full Text] [Related]
52. Characterization of fortilin, a novel antiapoptotic protein.
Li F; Zhang D; Fujise K
J Biol Chem; 2001 Dec; 276(50):47542-9. PubMed ID: 11598139
[TBL] [Abstract][Full Text] [Related]
53. Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction.
Wu TY; Wagner KW; Bursulaya B; Schultz PG; Deveraux QL
Chem Biol; 2003 Aug; 10(8):759-67. PubMed ID: 12954335
[TBL] [Abstract][Full Text] [Related]
54. Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex.
Kim KS; Heo JI; Choi KJ; Bae S
Cancer Biol Ther; 2014; 15(12):1622-34. PubMed ID: 25535897
[TBL] [Abstract][Full Text] [Related]
55. Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
Ekedahl J; Joseph B; Grigoriev MY; Müller M; Magnusson C; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2002 Oct; 279(2):277-90. PubMed ID: 12243753
[TBL] [Abstract][Full Text] [Related]
56. Domain organization of XAF1 and the identification and characterization of XIAP(RING) -binding domain of XAF1.
Tse MK; Cho CK; Wong WF; Zou B; Hui SK; Wong BC; Sze KH
Protein Sci; 2012 Oct; 21(10):1418-28. PubMed ID: 22811387
[TBL] [Abstract][Full Text] [Related]
57. Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
Cillessen SA; Reed JC; Welsh K; Pinilla C; Houghten R; Hooijberg E; Deurhof J; Castricum KC; Kortman P; Hess CJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Blood; 2008 Jan; 111(1):369-75. PubMed ID: 17916749
[TBL] [Abstract][Full Text] [Related]
58. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer.
Huang J; Yao WY; Zhu Q; Tu SP; Yuan F; Wang HF; Zhang YP; Yuan YZ
Cancer Sci; 2010 Feb; 101(2):559-67. PubMed ID: 19922503
[TBL] [Abstract][Full Text] [Related]
59. XAF1 forms a positive feedback loop with IRF-1 to drive apoptotic stress response and suppress tumorigenesis.
Jeong SI; Kim JW; Ko KP; Ryu BK; Lee MG; Kim HJ; Chi SG
Cell Death Dis; 2018 Jul; 9(8):806. PubMed ID: 30042418
[TBL] [Abstract][Full Text] [Related]
60. XIAP-associating factor 1, a transcriptional target of BRD7, contributes to endothelial cell senescence.
Heo JI; Kim W; Choi KJ; Bae S; Jeong JH; Kim KS
Oncotarget; 2016 Feb; 7(5):5118-30. PubMed ID: 26802028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
